ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo

ClinicalTrials.gov ID: NCT06118411

Public ClinicalTrials.gov record NCT06118411. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 3:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects With Non-Segmental Vitiligo Who Are Eligible for Systemic Therapy

Study identification

NCT ID
NCT06118411
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
614 participants

Conditions and interventions

Conditions

Interventions

  • NB-UVB (narrow-band ultraviolet B) Phototherapy Other
  • Placebo Drug
  • Upadacitinib Drug

Other · Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 18, 2023
Primary completion
Sep 22, 2025
Completion
Jan 31, 2028
Last update posted
Nov 9, 2025

2023 – 2028

United States locations

U.S. sites
46
U.S. states
15
U.S. cities
38
Facility City State ZIP Site status
Advanced Research Associates - Glendale /ID# 259915 Glendale Arizona 85308
Alliance Dermatology and Mohs Center /ID# 259926 Phoenix Arizona 85032
Private Practice - Dr. Tooraj Raoof /ID# 260055 Encino California 91436
University of California Irvine /ID# 260080 Irvine California 92697-1385
Vitiligo & Pigmentation Institute of Southern California /ID# 259970 Los Angeles California 90036-5679
Dermatology Research Associates /ID# 260056 Los Angeles California 90045
Duplicate_Stanford University /ID# 260081 Redwood City California 94063
Integrative Skin Science and Research /ID# 260060 Sacramento California 95815
University of California Davis Health /ID# 260062 Sacramento California 95817
Clinical Trials Research Institute /ID# 259910 Thousand Oaks California 91320-2130
Skin Care Research Boca Raton /ID# 260094 Boca Raton Florida 33486-2269
Apex Clinical Trials /ID# 260096 Brandon Florida 33511
Florida Academic Dermatology Center /ID# 259919 Coral Gables Florida 33134-5755
Direct Helpers Research Center /ID# 259932 Hialeah Florida 33012
Skin Care Research - Hollywood /ID# 260101 Hollywood Florida 33021-6748
Encore Medical Research /ID# 259963 Hollywood Florida 33021
GSI Clinical Research, LLC /ID# 259918 Margate Florida 33063
Life Clinical Trials /ID# 260097 Margate Florida 33063
Savin Medical Group, LLC /ID# 259968 Miami Lakes Florida 33014
Advanced Clinical Research Institute /ID# 260058 Tampa Florida 33607
Encore Medical Research - Weston /ID# 260542 Weston Florida 33331
Cleaver Medical Group Dermatology /ID# 259925 Dawsonville Georgia 30534
DeNova Research /ID# 260611 Chicago Illinois 60610
Indiana University Health University Hospital /ID# 259974 Indianapolis Indiana 46202
Dawes Fretzin, LLC /ID# 260068 Indianapolis Indiana 46256
Tufts Medical Center /ID# 260088 Boston Massachusetts 02111-1552
UMass Memorial Medical Center /ID# 259921 Worcester Massachusetts 01605
Oakland Hills Dermatology /ID# 260602 Auburn Hills Michigan 48326
Great Lakes Research Group - Bay City /ID# 260600 Bay City Michigan 48706
Hamzavi Dermatology - Canton /ID# 260545 Canton Michigan 48187
Clarkston Dermatology /ID# 260069 Clarkston Michigan 48346
Henry Ford Medical Center - New Center One /ID# 260059 Detroit Michigan 48202-3046
Minnesota Clinical Study Center /ID# 260154 New Brighton Minnesota 55112
Vivida Dermatology- Flamingo /ID# 260609 Las Vegas Nevada 89119-5190
Schweiger Dermatology, P.C. /ID# 260152 New York New York 07044-2946
Icahn School of Medicine at Mount Sinai /ID# 259909 New York New York 10029
DermResearchCenter of New York, Inc. /ID# 259906 Stony Brook New York 11790
ClinOhio Research Services /ID# 260300 Columbus Ohio 43213-4440
Oregon Medical Research Center /ID# 259911 Portland Oregon 97201
Oregon Dermatology and Research Center /ID# 259917 Portland Oregon 97210
Medical University of South Carolina /ID# 259916 Charleston South Carolina 29425
Bellaire Dermatology Associates /ID# 260044 Bellaire Texas 77401
Dermatology Treatment and Research Center /ID# 260078 Dallas Texas 75230
Innovative Dermatology - Plano /ID# 260628 Plano Texas 75024
Dermatology Clinical Research Center of San Antonio /ID# 260047 San Antonio Texas 78229
Progressive Clinical Research /ID# 260070 San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06118411, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 9, 2025 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06118411 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →